Study guide
14.2 Documentation, Coding & Reimbursement Standards
ABWM Certified Wound Specialist CWS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Overview
1.1 About the ABWM CWS Exam 1.2 How to Use This Study Guide & Blueprint Strategy
2 Chapter 2: Comprehensive Patient & Wound Assessment
2.1 Patient History & Systemic Risk Factors 2.2 Physical Examination & Anatomical Wound Classification 2.3 Quantitative Wound Measurement & Documentation 2.4 Bioburden & Infection Assessment
3 Chapter 3: Vascular Assessment & Diagnostic Testing
Section 3.1: Ankle-Brachial Index (ABI) & Toe-Brachial Index (TBI) Interpretation Section 3.2: Advanced Vascular Diagnostics Section 3.3: Neuropathic & Sensory Assessment
4 Chapter 4: Laboratory, Imaging & Diagnostic Approaches
Section 4.1: Laboratory Evaluation in Wound Care Section 4.2: Imaging Modalities for Wounds & Bone Section 4.3: Differential Diagnosis of Recalcitrant & Atypical Wounds
5 Chapter 5: Physiology of Wound Healing & Tissue Repair
5.1 Hemostasis & Inflammatory Phase Dynamics 5.2 Proliferative & Remodeling Phases 5.3 Growth Factors & Extracellular Matrix (ECM)
6 Chapter 6: Biofilm Biology & Wound Bed Preparation
6.1 Biofilm Pathophysiology & Management Strategies 6.2 TIME Framework & Wound Bed Preparation 6.3 Moisture Balance & Exudate Management
7 Chapter 7: Pressure Injuries & Moisture-Associated Skin Damage
7.1 Pressure Injury Pathophysiology & NPIAP Staging 7.2 Risk Assessment Tools & Support Surface Selection 7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis
8 Chapter 8: Lower Extremity Ulcers (Venous, Arterial & Mixed)
Section 8.1: Venous Leg Ulcers & CEAP Classification Section 8.2: Arterial Ulcers & Peripheral Artery Disease Section 8.3: Mixed Venous-Arterial Ulcers & Lymphedema
9 Chapter 9: Diabetic Foot Ulcers & Neuropathic Wounds
Section 9.1: Diabetic Foot Ulcer Pathophysiology & Classification Section 9.2: Diabetic Foot Infection & Osteomyelitis Management
10 Chapter 10: Thermal Injuries, Surgical Wounds & Special Etiologies
Section 10.1: Burn Injuries & Thermal Damage Section 10.2: Surgical Wounds, Dehisced Incisions & Fistulas Section 10.3: Dermatological, Pediatric & Miscellaneous Wound Types
11 Chapter 11: Debridement & Topically Applied Therapies
Section 11.1: Debridement Modalities & Selection Section 11.2: Wound Dressing Selection & Categories Section 11.3: Topical Antimicrobial Agents & Antiseptics
12 Chapter 12: Compression Therapy & Advanced Off-Loading
Section 12.1: Compression Therapy Modalities & Science Section 12.2: Off-Loading Devices & Biomechanical Protection
13 Chapter 13: Advanced & Adjunctive Wound Therapies
Section 13.1: Negative Pressure Wound Therapy (NPWT) Section 13.2: HBOT, Biophysical Agents & Advanced Biologics Section 13.3: Systemic Nutrition, Hydration & Pain Management
14 Chapter 14: Professional Practice, Reimbursement & Interprofessional Care
14.1 Professional Ethics, Scope of Practice & ABWM Guidelines 14.2 Documentation, Coding & Reimbursement Standards 14.3 Interprofessional Team Roles & Quality Improvement
14.2 Documentation, Coding & Reimbursement Standards
Key Takeaways Explain This Topic AI
Essential medical record documentation for reimbursement must include 3D wound dimensions (length, width, depth), undermining/tunneling, bed tissue percentages, periwound status, exudate, and measurable progress toward goals.
CPT codes 97597 and +97598 represent selective debridement techniques (autolytic, enzymatic, mechanical, high-pressure waterjet, ultrasonic) up to and over 20 sq cm.
CPT codes 11042–11047 represent excisional/surgical debridement categorized strictly by the deepest tissue level excised (subcutaneous, muscle/fascia, bone).
Medicare Local Coverage Determinations (LCDs) strictly enforce medical necessity criteria, requiring documented failure of standard care for ≥ 4 weeks before approving advanced CTPs, NPWT, or HBOT.
Last updated: July 2026
Documentation, Coding & Reimbursement Standards
Accurate documentation, procedural coding, and compliance with third-party reimbursement guidelines are vital components of sustainable wound care practice. The Centers for Medicare & Medicaid Services (CMS), commercial insurers, and audit entities mandate strict documentation standards to justify the medical necessity of wound care interventions, procedures, and advanced biological modalities. Inadequate or imprecise documentation results in claim denials, post-payment clawbacks, and potential allegations of healthcare fraud.
Essential Medical Record Documentation for Reimbursement
To establish medical necessity for wound evaluation, debridement, and advanced therapies, the medical record must contain consistent, objective quantitative and qualitative documentation recorded at every clinical encounter.
Required Clinical Documentation Elements
Etiology & Anatomic Location: Specific diagnostic etiology (e.g., stage 4 sacral pressure injury, diabetic foot ulcer of plantar first metatarsal head, venous stasis ulcer of medial malleolus) and exact anatomical site.
Quantitative Wound Measurements:
3D Dimensions: Length (head-to-toe axis) x Width (side-to-side axis) x Depth (deepest point), measured in centimeters (cm).
Undermining & Tunneling: Measured in depth (cm) and mapped using the clock-face method (12:00 toward patient's head).
Surface Area & Volume: Calculation of total surface area ( c m 2 cm^2 c m 2 ) to track healing trajectories.
Wound Bed Description: Percentage breakdown of tissue types present in the wound bed:
Granulation tissue (red, viable, vascularized tissue).
Slough (yellow, soft, moist avascular tissue).
Eschar (black/brown, hard, dry necrotic tissue).
Epithelialization (pinkish skin advancing from wound margins).
Exudate Assessment: Quantity (none, scant, moderate, heavy) and character (serous, serosanguinous, sanguineous, purulent) and presence/absence of foul odor.
Periwound Assessment: Condition of surrounding skin within 4 cm of wound edge (e.g., intact, macerated, erythematous, indurated, hyperkeratotic, callus, dark dusky discoloration).
Pain Assessment: Quantitative pain score (0–10 scale) and pain characteristics (e.g., neuropathic, throbbing, dressing-change related).
Infection Status: Presence or absence of localized signs (NERDS: Non-healing, Exudate increase, Red/bleeding tissue, Debris, Smell) or systemic signs (STONEES: Size increase, Temperature elevation, Os [exposed bone], New breakdown, Exudate, Erythema/Edema).
Treatment Plan & Clinical Rationale: Detailed justification for selected dressings, topicals, off-loading devices, compression levels, or advanced modalities.
Measurable Progress Toward Goals: Explicit documentation of healing velocity. Medicare guidelines generally expect a 20% to 40% reduction in wound surface area over 2 to 4 weeks of standard wound management. If progress is absent, documentation must justify changing the care plan or initiating advanced therapies.
CPT Debridement Coding & Procedural Rules
Current Procedural Terminology (CPT) codes for wound debridement are categorized into two primary procedural classifications: Selective Debridement (97597–97598) and Somatic/Surgical Excisional Debridement (11042–11047).
1. Selective Debridement (CPT 97597 & 97598)
Selective debridement involves the specific removal of non-viable, necrotic tissue using technique modalities such as high-pressure waterjet, ultrasonic debridement, sharp scissors/scalpel/curette selective removal without excise of viable tissue, autolytic, or enzymatic methods.
CPT 97597: Debridement, open wound, selective (e.g., high-pressure waterjet with / without suction, sharp selective debridement with scalpel, scissors, forceps, curette), includes topical application(s), wound assessment, epidermal / dermal tissue, first 20 sq cm or less .
CPT +97598: Each additional 20 sq cm, or part thereof (Add-on code, list separately in addition to code for primary procedure 97597).
2. Surgical / Somatic Excisional Debridement (CPT 11042–11047)
Excisional debridement involves the surgical removal of devitalized tissue using a scalpel, curette, or scissors, extending down into or through specific anatomical tissue layers. Coding is governed strictly by the deepest level of tissue removed.
- CPT Code Tissue Depth Description Surface Area Unit
- 11042 Subcutaneous tissue debridement First 20 sq cm or less
- +11045 Subcutaneous tissue debridement Each additional 20 sq cm, or part thereof
- 11043 Muscle and/or fascia debridement First 20 sq cm or less
- +11046 Muscle and/or fascia debridement Each additional 20 sq cm, or part thereof
- 11044 Bone debridement (includes muscle/subcutaneous) First 20 sq cm or less
- +11047 Bone debridement Each additional 20 sq cm, or part thereof
- Critical Debridement Coding Rules
Deepest Level Rule: Code selection is based on the deepest tissue level excised. If a single wound contains areas of subcutaneous tissue and exposed muscle, and muscle tissue is excisively debrided, the entire procedure for that wound is coded under 11043 (+11046 if surface area > 20 c m 2 cm^2 c m 2 ).
Summing Surface Area: If multiple wounds are debrided at the same anatomical depth , sum the total surface area of all wounds at that depth before selecting primary and add-on codes.
Excisional vs. Non-Excisional: Excisional debridement requires cutting away tissue down into viable tissue margins. Washing, scrubbing, or applying topical enzymes without sharp tissue excision cannot be coded under 11042–11047.
Modifier -25: Append to Evaluation & Management (E/M) codes when a significant, separately identifiable E/M service is provided on the same day as a debridement procedure.
Modifier -59 / XS: Used to indicate distinct procedural services performed on separate anatomical lesions during the same encounter.
Medicare Local Coverage Determinations (LCDs) & Medical Necessity
Medicare Administrative Contractors (MACs) publish Local Coverage Determinations (LCDs) establishing specific clinical coverage criteria, frequency limitations, and required prior documentation for advanced wound care interventions.
1. Cellular and/or Tissue-Based Products (CTPs / Skin Substitutes)
Documented Standard Care Failure: LCDs mandate that the wound must have failed to achieve adequate healing (typically < 40–50% area reduction) after at least 4 consecutive weeks of documented standard wound therapy (adequate off-loading, infection control, compression, moisture balance).
Vascular Adequacy: Objective evidence of adequate arterial perfusion prior to application (ABI ≥ \ge ≥ 0.70, Toe-Brachial Index [TBI] ≥ \ge ≥ 0.50, or Transcutaneous Oxygen Pressure [ T c P O 2 ] ≥ 30 [TcPO_2] \ge 30 [ T c P O 2 ] ≥ 30 mmHg).
Application Limits: LCDs typically restrict total applications (e.g., maximum of 4 to 8 applications within a 12-week episode of care depending on MAC policy).
2. Negative Pressure Wound Therapy (NPWT)
Outpatient/DMEPOS Criteria: Requires documentation of a chronic, non-healing stage 3/4 pressure injury, neuropathic DFU, venous ulcer, or dehisced surgical wound.
Prior Standard Care: Documented trial of appropriate standard dressings without healing progress.
Contraindications to Document: NPWT is strictly contraindicated in wounds with non-cleared necrotic eschar, untreated osteomyelitis, exposed vital organs/vessels, active malignancy in the wound, or non-enteric/unexplored fistulas.
3. Hyperbaric Oxygen Therapy (HBOT)
CMS Approved Indications: Includes Wagner Grade 3, 4, or 5 diabetic foot ulcers; chronic refractory osteomyelitis; compromised skin grafts or flaps; osteoradionecrosis and soft tissue radionecrosis; acute crush injury/peripheral arterial ischemia.
30-Day Failure Requirement for DFUs: For diabetic foot ulcers, Medicare requires documented failure of standard wound care for at least 30 days before HBOT initiation, alongside objective vascular assessment (ABI/TBI/ T c P O 2 TcPO_2 T c P O 2 ).